Category Filter
Policies & Guidelines
- Advanced Imaging
- Autism Spectrum Mandate
- Behavioral Health
- Blue Advantage Policies
- Chronic Condition Management
- Genetic Testing
- HealthSmartRx Smart RxAssist Program
- Hemophilia Drugs
- Medical Oncology Regimen Program
- Medical Policies
- Pharmacy
- Pre-Service Review (Precertification and Predetermination)
- Pre-Service Review (Precertification/Predetermination)
- Pre-Service Review (Predetermination/Precertification)
- Provider-Administered Drug Policies
- Radiation Therapy
- Self-Administered Drug Policies
- Transgender Services
Asset Publisher
print
Print
Back
Back
Bariatric Surgery for Treatment of Morbid Obesity and GERD
Policy Number: MP-053
Latest...
print
Print
Back
Back
Bi-Ventricular Pacemakers (Cardiac Resynchronization Therapy) for the Treatment of Heart...
print
Print
Back
Back
Reduction Mammaplasty
Policy Number: MP-056
Latest Review Date: February 2024
Category:...
print
Print
Back
Back
Management of Excessive Skin and Subcutaneous Tissue
Policy Number: MP-058
Latest...
print
Print
Back
Back
Enhanced External Counterpulsation (EECP)
Policy Number: MP-059
Latest Review Date:...
print
Print
Back
Back
Hyperbaric Oxygen Therapy
Policy Number: MP-060
Latest Review Date: September 2024
...
print
Print
Back
Back
High Sensitivity C-Reactive Protein
Policy Number: MP-062
Latest Review Date: May 2024
...
print
Print
Back
Back
Fetal Fibronectin Enzyme Immunoassay
Policy Number: MP-063
Latest Review Date: May...
print
Print
Back
Back
Quantitative Sensory Testing (QST)
Policy Number: MP-066
Latest Review Date: June...
print
Print
Back
Back
Ultrasound of the Spinal Canal
Policy Number: MP-069
Latest Review Date: June 2024
...
print
Print
Back
Back
Locoregional Therapies for Primary or Metastatic Liver Tumors
Policy Number: MP-070...
print
Print
Back
Back
Extracorporeal Shock Wave Treatment for Plantar Fasciitis and Other Musculoskeletal...
print
Print
Back
Back
Home Prothrombin Time Testing (INR Monitoring)
Policy Number: MP-078
Latest Review...